These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14616381)

  • 1. Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream.
    Nagore E; Sevila A; Sanmartin O; Botella-Estrada R; Requena C; Serra-Guillen C; Sanchez-Pedreño P; Guillen C
    Br J Dermatol; 2003 Oct; 149(4):858-61. PubMed ID: 14616381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
    Yang JQ; Chen XY; Engle MY; Wang JY
    Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.
    Weisberg NK; Varghese M
    Dermatol Surg; 2002 Jun; 28(6):518-23. PubMed ID: 12081683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream.
    Malhotra AK; Gupta S; Khaitan BK; Verma KK
    Pediatr Dermatol; 2008; 25(4):488-91. PubMed ID: 18789101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum.
    Roseeuw D
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():30-2. PubMed ID: 14616810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin.
    Giannotti B; Vanzi L; Difonzo EM; Pimpinelli N
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():33-5. PubMed ID: 14616811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient with xeroderma pigmentosum treated with imiquimod 5% cream.
    Nijsten T; Lapière K; Lambert J
    J Am Acad Dermatol; 2005 Jan; 52(1):170-1. PubMed ID: 15627108
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
    Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 12. Photodynamic therapy in the treatment of xeroderma pigmentosum: A case report.
    Cai H; Yang QQ; Ma C; Zou DX; Wang YX; Sun P; Ju AQ; Fang F; Gong S; Liu W
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101761. PubMed ID: 32283311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of vismodegib for the treatment of multiple basal cell carcinomas in a patient with xeroderma pigmentosum.
    Soura E; Plaka M; Dessinioti C; Chasapi V; Stefanaki C; Antoniou C; Stratigos A
    Pediatr Dermatol; 2018 Nov; 35(6):e334-e336. PubMed ID: 30178564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients.
    Vidal D; Alomar A
    Clin Exp Dermatol; 2004 May; 29(3):237-9. PubMed ID: 15115500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod - Its role in the treatment of cutaneous malignancies.
    Bubna AK
    Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
    Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
    Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
    Warshauer E; Warshauer BL
    J Drugs Dermatol; 2008 May; 7(5):447-51. PubMed ID: 18505136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
    Oster-Schmidt C; Altmeyer P; Stücker M
    Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.